Bibliography

Citation 1, 5, 8, 45, 48:

• Rupp ME, Cavalieri RJ, Marolf C, Lyden E. Reduction in blood culture contamination through use of Initial Specimen Diversion Device. Clin Infect Dis. 2017;65(2):201-205. doi:10.1093/cid/cix304.
• Arenas M, Boseman GM, Coppin JD, Lukey J, Jinadatha C, Navarathna DH. Asynchronous testing of 2 specimen-diversion devices to reduce blood culture contamination: a single-site product supply quality improvement project. J Emerg Nurs. 2021;47(2):256-264.e6. doi:10.1016/j.jen.2020.11.008.
• Tompkins LS, et al. Getting to zero: impact of a device to reduce blood culture contamination and false-positive central line-associated blood stream infections. Submitted for publication in December 2021.

Citation 2:

• Geisler BP, Jilg N, Patton RG, Pietzsch JB. Model to evaluate the impact of hospital-based interventions targeting false-positive blood cultures on economic and clinical outcomes. J Hosp Infect. 2019;102(4):438-444. doi:10.1016/j.jhin.2019.03.012.
• Nielsen LE, Nguyen K, Wahl CK, et al. Initial Specimen Diversion Device® reduces blood culture contamination and vancomycin use in academic medical center. J Hosp Infect. 2021;117. doi:https://doi.org/10.1016/j.jhin.2021.10.017.
• Zwang O, Albert RK. Analysis of strategies to improve cost effectiveness of blood cultures. J Hosp Med. 2006;1(5):272-6. doi:10.1002/jhm.115.
• Fridkin S, Baggs J, Fagan R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014;63(9):194–200.
• Owens RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46(Suppl 1):S19-31. doi:10.1086/521859.
• Khalili H, Bairami S, Kargar M. Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome. Acta Med Iran. 2013;51(12):871-8.
• Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol. 2012;68(9):1243-55. doi:10.1007/s00228-012-1259-9.
• Bellos I, Karageorgiou V, Pergialiotis V, Perrea DN. Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis. Clin Microbiol Infect. 2020;26(6):696-705. doi:10.1016/j.cmi.2020.03.019.

Citation 3, 4, 9, 25, 47:

Indicated to reduce the frequency of blood culture contamination when contaminants are present, compared to standard method controls without diversion.

• Design fact as indicated in K192247 (Steripath Gen2 Blood Collection System FDA clearance letter).

Citation 6:

• Patton RG, Schmitt T. Innovation for reducing blood culture contamination: initial specimen diversion technique. J Clin Microbiol. 2010;48(12):4501-3. doi:10.1128/JCM.00910-10.

Citation 18:

• Patton RG, Schmitt T. Innovation for reducing blood culture contamination: initial specimen diversion technique. J Clin Microbiol. 2010;48(12):4501-3. doi:10.1128/JCM.00910-10.
• Zimmerman FS, Karameh H, Ben-Chetrit E, Zalut T, Assous M, Levin PD. Modification of blood test draw order to reduce blood culture contamination: a randomized clinical trial. Clin Infect Dis. 2020;71(5):1215-1220. doi:10.1093/cid/ciz971.
• Binkhamis K, Forward K. Effect of the initial specimen diversion technique on blood culture contamination rates. J Clin Microbiol. 2014;52(3):980-1. doi:10.1128/JCM.02773-13.

Citation 11, 50:

• Patton RG. Blood culture contamination definitions can obscure the extent of blood culture contamination: a new standard for satisfactory institution performance Is needed. Infect Control Hosp Epidemiol. 2016;37(6):736-8. doi:10.1017/ice.2016.30.

Citation 12, 32:

• Anjanappa T, Arjun A. Preparative skin preparation and surgical wound infection. J Evid Based Med. 2015;2(2):131-154. doi:https://doi.org/10.18410/jebmh/19.

Citation 13, 33:

• Zwang O, Albert RK. Analysis of strategies to improve cost effectiveness of blood cultures. J Hosp Med. 2006;1(5):272-6. doi:10.1002/jhm.115.
• Fridkin S, Baggs J, Fagan R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014;63(9):194–200.
• Owens RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46(Suppl 1):S19-31. doi:10.1086/521859.

Citation 14, 29, 34:

• Khalili H, Bairami S, Kargar M. Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome. Acta Med Iran. 2013;51(12):871-8.
• Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol. 2012;68(9):1243-55. doi:10.1007/s00228-012-1259-9.
• Bellos I, Karageorgiou V, Pergialiotis V, Perrea DN. Acute kidney injury following the concurrent administration of antipseudomonal β-lactams and vancomycin: a network meta-analysis. Clin Microbiol Infect. 2020;26(6):696-705. doi:10.1016/j.cmi.2020.03.019.

Citation 15, 35:

• Geisler BP, Jilg N, Patton RG, Pietzsch JB. Model to evaluate the impact of hospital-based interventions targeting false-positive blood cultures on economic and clinical outcomes. J Hosp Infect. 2019;102(4):438-444. doi:10.1016/j.jhin.2019.03.012.

Citation 16:

• Kim N, Kim M, Lee S, et al. Effect of routine sterile gloving on contamination rates in blood culture: a cluster randomized trial. Ann Intern Med. 2011;154:145-151. doi:10.7326/0003-4819-154-3-201102010-00003.

Citation 17:

• Liu V, Escobar GJ, Greene JD. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014;312(1):90-92. doi:10.1001/jama.2014.5804.
• Weiss AJ, Jiang HJ. Overview of clinical conditions with frequent and costly hospital readmissions by payer, 2018. HCUP Statistical Brief #278. July 2021. Agency for Healthcare Research and Quality, Rockville, MD.

Citation 19, 44:

• Tompkins LS, et al. Getting to zero: impact of a device to reduce blood culture contamination and false-positive central line-associated blood stream infections. Submitted to Clin Infect Dis in December 2021.

Citation 20:

• Rupp ME, Cavalieri RJ, Marolf C, Lyden E. Reduction in blood culture contamination through use of Initial Specimen Diversion Device. Clin Infect Dis. 2017;65(2):201-205. doi:10.1093/cid/cix304.

Citation 21, 31:

• Nielsen LE, Nguyen K, Wahl CK, et al. Initial Specimen Diversion Device® reduces blood culture contamination and vancomycin use in academic medical center. J Hosp Infect. 2021;117. doi:https://doi.org/10.1016/j.jhin.2021.10.017.

Citation 22:

• Skoglund E, Dempsey CJ, Chen H, Garey KW. Estimated clinical and economic impact through use of a novel blood collection device to reduce blood culture contamination in the emergency department: a cost-benefit analysis. J Clin Microbiol. 2019;57(1):e01015-18. doi:10.1128/JCM.01015-18.
• Geisler BP, Jilg N, Patton RG, Pietzsch JB. Model to evaluate the impact of hospital-based interventions targeting false-positive blood cultures on economic and clinical outcomes. J Hosp Infect. 2019;102(4):438-444. doi:10.1016/j.jhin.2019.03.012.

Citation 23:

• Geisler BP, Jilg N, Patton RG, Pietzsch JB. Model to evaluate the impact of hospital-based interventions targeting false-positive blood cultures on economic and clinical outcomes. J Hosp Infect. 2019;102(4):438-444. doi:10.1016/j.jhin.2019.03.012.

Citation 24, 40, 46:

• CLSI. Principles and Procedures for Blood Cultures; Approved Guidelines. CLSI document M47-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
• Zwang O, Albert RK. Analysis of strategies to improve cost effectiveness of blood cultures. J Hosp Med. 2006;1(5):272-6. doi:10.1002/jhm.115.

Citation 27:

• CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019. doi:http://dx.doi.org/10.15620/cdc:82532.

Citation 28:

• Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017;177(9):1308–1315. doi:10.1001/jamainternmed.2017.1938.

Citation 37, 38, 52:

• Bell M, Bogar C, Plante J, Rasmussen K, Winters S. Effectiveness of a novel specimen collection system in reducing blood culture contamination rates. J Emerg Nurs. 2018;44(6):570-575. doi:10.1016/j.jen.2018.03.007.
• Arenas M, Boseman GM, Coppin JD, Lukey J, Jinadatha C, Navarathna DH. Asynchronous testing of 2 specimen-diversion devices to reduce blood culture contamination: a single-site product supply quality improvement project. J Emerg Nurs. 2021;47(2):256-264.e6. doi:10.1016/j.jen.2020.11.008.
• Zimmerman FS, Assous MV, Zevin S, Wiener-Well Y. Reducing blood culture contamination using an Initial Specimen Diversion Device. Am J Infect Control. 2019;47(7):822-826. doi:10.1016/j.ajic.2018.12.004.
• Nielsen LE, Nguyen K, Wahl CK, et al. Initial Specimen Diversion Device® reduces blood culture contamination and vancomycin use in academic medical center. J Hosp Infect. 2021;117. doi:https://doi.org/10.1016/j.jhin.2021.10.017.
• Povroznik MD. Initial Specimen Diversion Device® utilization mitigates blood culture contamination across regional community hospital and acute care facility. Am J Med Qual. 2022. doi:10.1097/JMQ.0000000000000055.
• Gauld LL, Palmer-Long GE, Michael S, Steed LL. Reducing the laboratory cost of false positive blood cultures in the adult emergency department. Presented at Institute for Healthcare Improvement National Forum 2016, Orlando, Florida.
• Church K, Palmer-Long GE, Cumins N, et al. Novel blood culture collection device reduces false-positive blood cultures, saves costs, and increases accuracy of bloodstream infection diagnosis. Presented at the Institute of Healthcare Improvement National Forum 2017, Orlando, Florida.
• Merola C. Initial specimen diversion device associated with a 94% lower blood culture contamination rate. Presented at Emergency Nursing 2021, Orlando, Florida.
• Schaefer C. Antimicrobial stewardship standards and patient safety: a case study in blood culture contamination. Antimicrobial Stewardship & Healthcare Epidemiology. 2021;1(S1):S36-S36. doi:10.1017/ash.2021.66.
• Poteet G, Parrish C. Reducing blood culture contamination: new best practice tool. Presented at AONL 2020 Virtual Conference.
• Brownfield K, Peterson, M. Emergency department observes 83% reduction in blood culture contamination with initial specimen diversion technology adoption. Am J Infect Control. 2021;49(6):S14. doi:https://doi.org/10.1016/j.ajic.2021.04.052.
• Stonecypher K, Noble J. ER pilot leads to hospital-wide implementation of blood culture device. Presented at Emergency Nursing 2018, Pittsburgh, Pennsylvania.
• Bauman K. Don’t stick me again! Reducing Blood Culture Contamination. Presented at Emergency Nursing 2019, Austin, Texas.

Citation 39:

• Gorski LA, Hadaway L, Hagle ME, et al. Infusion therapy standards of practice, 8th edition. J Infus Nurs. 2021 Jan-Feb 01;44(1S Suppl 1): S1-S224.doi: 10.1097/NAN.0000000000000396.
• Vanhoy MA, Horigan A, Kaiser J, et al. Emergency Nurses Association (ENA). Clinical practice guideline: prevention of blood culture contamination. 2020.

Citation 41:

• Tompkins LS, et al. Getting to zero: impact of a device to reduce blood culture contamination and false-positive central line-associated blood stream infections. Submitted to Clin Infect Dis in December 2021.

Citation 42:

• Boyce JM, Nadeau J, Dumigan D, et al. Obtaining blood cultures by venipuncture versus from central lines: impact on blood culture contamination rates and potential effect on central line-associated bloodstream infection reporting. Infect Control Hosp Epidemiol. 2013;34(10):1042-7. doi:10.1086/673142.

Citation 43:

• Shuman EK, Washer LL, Arndt JL, et al. Analysis of central line-associated bloodstream infections in the intensive care unit after implementation of central line bundles. Infect Control Hosp Epidemiol. 2010;31(5):551-3. doi:10.1086/652157.

Citation 49:

• Geisler BP, Jilg N, Patton RG, Pietzsch JB. Model to evaluate the impact of hospital-based interventions targeting false-positive blood cultures on economic and clinical outcomes. J Hosp Infect. 2019;102(4):438-444. doi:10.1016/j.jhin.2019.03.012.

Citation 51:

• Rupp ME, Cavalieri RJ, Marolf C, Lyden E. Reduction in blood culture contamination through use of Initial Specimen Diversion Device. Clin Infect Dis. 2017;65(2):201-205. doi:10.1093/cid/cix304.
• Bell M, Bogar C, Plante J, Rasmussen K, Winters S. Effectiveness of a novel specimen collection system in reducing blood culture contamination rates. J Emerg Nurs. 2018;44(6):570-575. doi:10.1016/j.jen.2018.03.007.

Citation 53:

• Padoan A, Sirini S, Mazzone R, Mesiti C, Grillo C, Meyer B, Plebani M. Evaluation of an improved small gauge needle for venipuncture in children with difficult venous access: Impact on sample quality, phlebotomist satisfaction and patient pain perception. Clinica Chimica Acta. 2020; 500: 213-219.

Citation 54:

• Mouser A, Uettwiller-Geiger D, Plokhoy E, Berube J, Ahuja AJ, Stankovic AK. Evaluation of pain and specimen quality by use of a novel 25-gauge blood collection set With ultra-thin wall cannula and 5-bevel tip design. J Appl Lab Med. 2017;2(2):201-210.

Citation 55:

• Khare R, Kothari T, Castagnaro J, Hemmings B, Tso M, Juretschko S. Active monitoring and feedback to improve blood culture fill volumes and positivity across a large integrated health system. Clin Infect Dis. 2020;70(2):262-268.

Citation 56:

• FDA 510(k) clearance: K222299

---

If citations above are not linked, the publications are not available online.  Please contact us for references as needed.